Arovella Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:E4NA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Sep 24	Sell€3,936,525	Merchant Group Pty Ltd,Asset Management Arm	Company	6,502,098	€0.61
31 Aug 24	Buy€604,172	Merchant Funds Management Pty Ltd	Company	13,623,122	€0.051
31 Jul 24	Sell€628,051	Merchant Funds Management Pty Ltd	Company	11,313,335	€0.072
30 Jun 24	Buy€998,640	Merchant Group Pty Ltd,Asset Management Arm	Company	22,575,474	€0.044
30 Jun 24	Buy€322,644	Merchant Funds Management Pty Ltd	Company	7,800,000	€0.066
30 Apr 24	Buy€483,386	Merchant Group Pty Ltd,Asset Management Arm	Company	9,472,222	€0.051
30 Apr 24	Sell€131,831	Merchant Funds Management Pty Ltd	Company	2,000,000	€0.066
28 Mar 24	Buy€9,021	Thomas Duthy	Individual	103,000	€0.088
28 Mar 24	Buy€6,040	Gary Phillips	Individual	66,666	€0.091
27 Mar 24	Buy€18,865	Michael Baker	Individual	220,000	€0.086

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of E4NA?
Owner Type	Number of Shares	Ownership Percentage
Institutions	117,078,223	11.1%
Private Companies	124,358,413	11.7%
Individual Insiders	169,285,488	16%
General Public	648,666,405	61.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.5%.

Top Shareholders

Top 25 shareholders own 38.67% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.6%	Trust Company Funds Management Ltd.	59,369,000	€6.0m	0%	0.53%
5.45%	Merchant Group Pty Ltd,Asset Management Arm	57,709,223	€5.9m	79.4%	72.1%
4.81%	Mann Beef Pty Ltd	50,905,657	€5.2m	0%	no data
2.62%	Matthew Buckley	27,749,415	€2.8m	0%	no data
2.07%	James Hughes-Morris	21,917,196	€2.2m	0%	no data
1.97%	Daniel Phillips	20,834,940	€2.1m	0%	no data
1.95%	Blackburne Capital Pty Ltd	20,695,706	€2.1m	7.93%	no data
1.62%	Shahen Mekertichian	17,166,666	€1.7m	9.57%	no data
1.43%	Tk Cooper Holdings Pty Ltd	15,186,620	€1.5m	0%	no data
1.28%	M & M Stock One Pty Ltd	13,596,581	€1.4m	21.4%	no data
1.23%	Neil Delroy	13,067,222	€1.3m	26.6%	no data
1.18%	Peter Cook	12,543,194	€1.3m	0%	no data
1.13%	Murray James Way Pty Ltd	12,022,400	€1.2m	64.2%	no data
1.07%	Naomi Hughes-Morris	11,309,868	€1.2m	0%	no data
1.04%	Moovnup Pty Ltd	11,067,962	€1.1m	9.09%	no data
0.98%	Clive Jones	10,390,789	€1.1m	2.47%	no data
0.94%	Richard Mann	10,000,000	€1.0m	181%	no data
0.62%	Michael Baker	6,567,472	€669.2k	0%	no data
0.45%	Sharon Martin	4,782,485	€487.3k	0%	no data
0.45%	Brendan Martin	4,782,485	€487.3k	0%	no data
0.45%	Thomas Duthy	4,747,444	€483.8k	0%	no data
0.083%	Fresh Start Australia Pty Ltd	883,487	€90.0k	0%	no data
0.078%	Nicole van der Weerden	822,222	€83.8k	0%	no data
0.074%	Gary Phillips	788,888	€80.4k	0%	no data
0.074%	Gary Phillips	788,888	€80.4k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 13:27
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arovella Therapeutics Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Nidhi Singh	Edison Investment Research
Andrew Goodsall	MST Financial Services Pty Limited